Familial Hypercholesterolemia (FH) Summit Japan 2024
Satellite Symposium of the 56th Annual Meeting of Japan Atherosclerosis Society

Time & Date: 09:55 am – 3:55 pm, July 5th (Fri), 2024
Venue: Room 401 + 402, Kobe International Conference Center, Kobe, Japan
https://kobe-cc.jp/en/visitors/access/

This symposium is organized by the FH Committee of the Japan Atherosclerosis Society

  • Participation Free of Charge
  • Pre-registration is here

動脈硬化専門医更新単位:5単位付与(当日の芳名帳をもとに、学会事務局で単位付与いたします。単位申請等のお手続きは不要です)

Opening remarks

9:55-10:00
Hayato Tada (Kanazawa University) 

Pediatric FH Screening

<Session 1> 10:00-11:30

Chairpersons:

  • Tetsuo Minamino (Kagawa University)
  • Atsushi Nohara (Ishikawa Prefectural Central Hospital)
  1. Albert Wiegman (Amsterdam University Medical Centre)
    [Keynote lecture] Unlocking Insights in Familial Hypercholesterolemia Through Genetic Testing
  2. Keiji Matsunaga (Kagawa University)
    Universal Screening for Familial Hypercholesterolemia in Children in Kagawa, Japan
  3. Hiroaki Okazaki (Jichi Medical University)
    LDL-cholesterol screening in young adults – lessons learned from the Tokyo Young-FH study
  4. Kota Matsuki (Hirosaki University)
    Treatment of Pediatric Familial Hypercholesterolemia

Advanced Medical Therapies in FH

<Session 2> 11:40-12:30

Chairperson:

  • Ryuji Toh (Kobe University)
  1. Hayato Tada (Kanazawa University)
    Personalized Medicine in FH
  2. John Kastelein (Amsterdam University Medical Centre)
    Advanced Medical Therapies in FH

FH Academy

<Session 3> 12:40-14:10
Luncheon Seminar Sponsored by AMGEN K.K.

Chairpersons:

  • Stephen Nicholls (Monash University)
  • Mariko Harada-Shiba (Osaka Medical and Pharmaceutical University)
  1. Hayato Tada (Kanazawa University)
    The Current Situation of FH Diagnosis in Japan
  2. Masatsune Ogura (Juntendo University)
    FH Academy 2023: Summary Report
  3. Shinpei Fujioka (Osaka Medical and Pharmaceutical University)
    Applying FH academy to clinical practice

HoFH

<Session 4> 14:20-15:50
Sponsored by Ultragenyx Japan

Chairpersons:

  • Albert Wiegman (Amsterdam University Medical Centre)
  • Mariko Harada-Shiba (Osaka Medical and Pharmaceutical University)
  1. Mariko Harada-Shiba (Osaka Medical and Pharmaceutical University)
    Overview of Homozygous Familial Hypercholesterolemia
  2. Yasuaki Takeji (Kanazawa University)
    Clinical Characteristics of Homozygous Familial Hypercholesterolemia in Japan: insight from Japanese National Database
  3. Masahiro Koseki (Osaka University)
    The Efficacy and Safety of Evinacumab in Global and Japanese Patients with HoFH
  4. Yu Kataoka (National Cerebral & Cardiovascular Center)
    Atherosclerotic Plaques in HoFH Patients

Closing remarks

15:50-15:55
Mariko Harada-Shiba (Osaka Medical and Pharmaceutical University)